The article you requested is
Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder
Christopher Pittenger, MD, PhD; John H. Krystal, MD; and Vladimir Coric, MD
J Clin Psychiatry 2005;66(11):1492-1493 [letter]
© Copyright 2016 Physicians Postgraduate Press, Inc.
Article Abstract
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Sir: Self-injurious behavior (SIB) in patients with borderline
personality disorder (BPD), especially cutting, represents a
serious and often intractable clinical problem.
1 There are few
validated pharmacologic strategies for managing SIB.
1–3 We
describe our initial experience using glutamate-modulating
agents in 2 patients with BPD and prominent SIBs.